v3 Template
O

Orgenesis Inc.

Biotechnology ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$24.4M
Funding Rounds
8
Last Funding
2025-01-28

About Orgenesis Inc.

Orgenesis is a biotech company focused on unlocking the potential of cell and gene therapies (CGTs) to address challenging diseases. Their mission is to make these advanced therapies affordable, accessible, and standardized globally through innovative platforms and collaborations with academia, research institutes, and hospitals.

Products & Services

POCare Platform:A platform designed to provide a harmonized pathway for commercializing cell and gene therapies in an affordable and accessible format.
Orgenesis Mobile Processing Units and Labs™:A fully integrated, closed-loop, all-in-one bioprocessing unit for therapy production.
POCare Therapies:Focuses on bringing more and better therapy options to patients through partnerships and in-house development.
POCare Technology:Develops customized, automated systems for scalable and GMP-compliant therapy production at the point of care.
POCare Network:A collaborative network with global academia, research, and hospital partners to enable development, production, and distribution of therapies at the point of care.

Specialties

Cell and Gene Therapies (CGTs) Point of Care Therapy Production Bioprocessing Therapy Commercialization

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity Line of Credit
T: -
FT: Equity Line of Credit
A: 5000000
MR: -
FA: up to $5 million
FAN: 5000000
D: 2025-01-28
FD: 2025-01-28
1 investors
2 RT: Grant
T: -
FT: Grant
A: 1620000
MR: -
FA: €1.5 million
FAN: 1620000
D: 2024-03-13
FD: 2024-03-13
1 investors
3 RT: Private Placement
T: -
FT: Private Placement
A: 2300000
MR: -
FA: Approximately $2.3 million
FAN: 2300000
D: 2024-03-04
FD: 2024-03-04
1 investors
4 RT: Grant
T: -
FT: Grant
A: 2000000
MR: -
FA: €2.0 million
FAN: 2000000
D: 2024-02-29
FD: 2024-02-29
1 investors
5 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 1100000
MR: -
FA: 1.1 Million
FAN: 1100000
D: 2023-11-08
FD: 2023-11-08
1 investors
6 RT: Growth Investment
T: -
FT: Growth Investment
A: 5000000
MR: -
FA: $5 million
FAN: 5000000
D: 2023-05-10
FD: 2023-05-10
1 investors
7 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 3700000
MR: -
FA: $3.7 million
FAN: 3700000
D: 2023-02-27
FD: 2023-02-27
-
8 RT: Registered Direct
T: -
FT: Registered Direct
A: 3700000
MR: -
FA: 3.7 Million
FAN: 3700000
D: 2023-02-23
FD: 2023-02-23
1 investors
Equity Line of Credit Latest
2025-01-28
$5.0M
1 investor (Pro only)
Grant 2024-03-13
$1.6M
Private Placement 2024-03-04
$2.3M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

V

Vered Caplan

Chief Executive Officer of Orgenesis Inc.

LinkedIn (Pro only)
V

Victor Miller

Chief Financial Officer of Orgenesis

LinkedIn (Pro only)
H

Heiko von der Leyen

Medical Director

LinkedIn (Pro only)

Recent News

Orgenesis Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~30 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro